Viewing Study NCT00358657


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-02-24 @ 2:06 PM
Study NCT ID: NCT00358657
Status: TERMINATED
Last Update Posted: 2021-01-26
First Post: 2006-07-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders
Sponsor: Fred Hutchinson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2032.00
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None NIH View